Jeffrey Trigilio

Jeffrey Trigilio

Former Chief Financial OfficeratCullinan Therapeutics· In proxies 2022–2024

Pay in FY2024+82% from the year before · Cullinan Therapeutics stock +19.5% the same year

Jeffrey Trigilio was paid $4.0M in FY2024 (Dec), up 82%. Cullinan Therapeutics stock rose 19.5% that year.

Pay$100 in the stock at the end of FY21 → $79
Pay is from the Summary Compensation Table of each Cullinan Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Cullinan TherapeuticsPublic company · 4 yr
    • Former Chief Financial Officer2022 – Present · 4 yrStock in role -6%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?